• Overview
  • Tested Applications
  • Product Information
  • Publications (14)
  • Protocols
  • Reviews (1)
  • Related Products (5)

VEGFR3/FLT4 Polyclonal antibody

VEGFR3/FLT4 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse and More (1)

Applications

WB, IHC, IF, ELISA

Conjugate

Unconjugated

Cat no : 20712-1-AP

Synonyms

FLT4, Fms like tyrosine kinase 4, FLT41, FLT-4, FLT 4



Tested Applications

Positive WB detected inmouse spleen tissue, PC-3 cells, HeLa cells, mouse heart tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:200-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

20712-1-AP targets VEGFR3/FLT4 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse samples.

Tested Reactivity human, mouse
Cited Reactivityhuman, mouse, deer
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Peptide
Full Name fms-related tyrosine kinase 4
Calculated Molecular Weight 153 kDa
Observed Molecular Weight 125 kDa
GenBank Accession NumberNM_002020
Gene Symbol FLT4
Gene ID (NCBI) 2324
RRIDAB_10733474
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

FLT4, also named VEGFR-3, belongs to the protein kinase superfamily, Tyr protein kinase family, and CSF-1/PDGF receptor subfamily. It is a receptor for VEGFC. FLT4 has a tyrosine-protein kinase activity. Defects in FLT4 are the cause of lymphedema hereditary type 1 (LYH1A). Defects in FLT4 are found in juvenile hemangioma. The antibody is specific to FLT4.

Protocols

Product Specific Protocols
WB protocol for VEGFR3/FLT4 antibody 20712-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

  • Journal Impact Factor
  • Most recent
SpeciesApplicationTitle
humanIF

Mol Cancer

m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma

Authors - Han Fang
humanIHC

Front Oncol

The Specifically Androgen-Regulated Gene (SARG) Promotes Papillary Thyroid Carcinoma (PTC) Lymphatic Metastasis Through Vascular Endothelial Growth Factor C (VEGF-C) and VEGF Receptor 3 (VEGFR-3) Axis.

Authors - Shuai-Jun Xu
DeerWB

Stem Cell Res Ther

Deer thymosin beta 10 functions as a novel factor for angiogenesis and chondrogenesis during antler growth and regeneration.

Authors - Wei Zhang
humanWB

Pharmaceuticals (Basel)

Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells.

Authors - Nada Amri
humanWB

Mol Cell Endocrinol

Long noncoding RNA GAS5 accelerates diabetic wound healing and promotes lymphangiogenesis via miR-217/Prox1 axis.

Authors - Zhi-You He
humanWB

Oral Dis

Linagliptin's impact on lymphatic barrier and lymphangiogenesis in oral cancer with high glucose

Authors - Hongyu Wang

Reviews

The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.


FH

Shinford (Verified Customer) (12-15-2023)

We used the concentration of 1:500 to get a very strong band. It is a big volume set.

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:500
  • Cell Tissue Type: Lung cancer cell lines, lung cancer tissues
VEGFR3/FLT4 Antibody Western Blot validation (1:500 dilution) in Lung cancer cell lines, lung cancer tissues (Cat no:20712-1-AP)